These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17696819)

  • 1. T-cell receptor gene therapy for cancer: the progress to date and future objectives.
    Thomas S; Hart DP; Xue SA; Cesco-Gaspere M; Stauss HJ
    Expert Opin Biol Ther; 2007 Aug; 7(8):1207-18. PubMed ID: 17696819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy.
    Bobisse S; Zanovello P; Rosato A
    Expert Opin Biol Ther; 2007 Jun; 7(6):893-906. PubMed ID: 17555374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor gene therapy: critical parameters for clinical success.
    Linnemann C; Schumacher TN; Bendle GM
    J Invest Dermatol; 2011 Sep; 131(9):1806-16. PubMed ID: 21677669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor gene therapy for cancer.
    Schmitt TM; Ragnarsson GB; Greenberg PD
    Hum Gene Ther; 2009 Nov; 20(11):1240-8. PubMed ID: 19702439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
    Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
    Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects and limitations of T cell receptor gene therapy.
    Jorritsma A; Schotte R; Coccoris M; de Witte MA; Schumacher TN
    Curr Gene Ther; 2011 Aug; 11(4):276-87. PubMed ID: 21453279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.
    Bendle GM; Linnemann C; Hooijkaas AI; Bies L; de Witte MA; Jorritsma A; Kaiser AD; Pouw N; Debets R; Kieback E; Uckert W; Song JY; Haanen JB; Schumacher TN
    Nat Med; 2010 May; 16(5):565-70, 1p following 570. PubMed ID: 20400962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic engineering with T cell receptors.
    Zhang L; Morgan RA
    Adv Drug Deliv Rev; 2012 Jun; 64(8):756-62. PubMed ID: 22178904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redirecting T lymphocyte specificity by T cell receptor gene transfer--a new era for immunotherapy.
    Engels B; Uckert W
    Mol Aspects Med; 2007 Feb; 28(1):115-42. PubMed ID: 17307249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing.
    Govers C; Sebestyén Z; Coccoris M; Willemsen RA; Debets R
    Trends Mol Med; 2010 Feb; 16(2):77-87. PubMed ID: 20122868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
    Lu YC; Parker LL; Lu T; Zheng Z; Toomey MA; White DE; Yao X; Li YF; Robbins PF; Feldman SA; van der Bruggen P; Klebanoff CA; Goff SL; Sherry RM; Kammula US; Yang JC; Rosenberg SA
    J Clin Oncol; 2017 Oct; 35(29):3322-3329. PubMed ID: 28809608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen Selection for Enhanced Affinity T-Cell Receptor-Based Cancer Therapies.
    Hickman ES; Lomax ME; Jakobsen BK
    J Biomol Screen; 2016 Sep; 21(8):769-85. PubMed ID: 26993321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
    Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
    Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced T cell receptor gene therapy for cancer.
    Kieback E; Uckert W
    Expert Opin Biol Ther; 2010 May; 10(5):749-62. PubMed ID: 20201709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral Vectors for Cancer Gene Therapy.
    Schambach A; Morgan M
    Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting T cell receptor genes for cancer immunotherapy.
    Xue S; Gillmore R; Downs A; Tsallios A; Holler A; Gao L; Wong V; Morris E; Stauss HJ
    Clin Exp Immunol; 2005 Feb; 139(2):167-72. PubMed ID: 15654813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells.
    Hudecek M; Gogishvili T; Monjezi R; Wegner J; Shankar R; Kruesemann C; Miskey C; Ivics Z; Schmeer M; Schleef M
    Recent Results Cancer Res; 2016; 209():37-50. PubMed ID: 28101686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-cell Receptor Gene Therapy.
    Hinrichs CS
    Clin Cancer Res; 2016 Apr; 22(7):1559-64. PubMed ID: 27037253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies.
    Schmitt TM; Stromnes IM; Chapuis AG; Greenberg PD
    Clin Cancer Res; 2015 Dec; 21(23):5191-7. PubMed ID: 26463711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.